Clinical Trial Update: Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on intravenous gentamicin therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• Gentamicin (gentamicin)

Snippet

Sponsor: University of Southern California | Conditions: Recessive Dystrophic Epidermolysis Bullosa | Phase 1, Phase 2 | Status: UNKNOWN